Prophylactic cranial irradiation in non-small cell lung cancer

Annals of Oncology

Volumn 17, Issue SUPPL. 2, 2006, Pages

  Frezza, G ^a   Salvi, F ^a  

^a BELLARIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; EARLY DIAGNOSIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MEDIASTINUM LYMPH NODE; METASTASIS POTENTIAL; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOSURGERY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIATION ONCOLOGY; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33645827780     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj931     Document Type: Article

References (22)

1. Furuse K, Kubota K, Kqwahara M et al. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non small cell lung cancer. J Clin Oncol 1995; 13: 869-875.
2. Albain KS, Rusch VW, Crowley JJ et al. Concurrent Cisplatin/Etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non small cell lung cancer. J Clin Oncol 1995; 13: 1880-1892.
3. Stuschke M, Eberhardt W, Pottgen C et al. Prophylactic cranial irradiation in locally advanced non small cell lung cancer after multimodality treatment: Long term follow up and evaluation of late neuropsychologic effects. J Clin Oncol 1999; 17: 2700-2709.
4. Strauss GM, Herndon JE, Sherman DD et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in non small cell cancer of the lung. J Clin Oncol 1992; 10: 1237-1244.
5. Cox JD, Stanley K, Petrovich Z et al. Cranial irradiation in cancer of the lung of all cell types. J Am Med Assoc 1981; 245: 469-472.
6. Russel AH, Pajak TE, Selim HM et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastases. Int J Radiat Oncol Biol Phys 1991; 21: 637-643.
7. Umsawadi T, Valdivieso M, Chen TT et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non small cell lung cancer. J Neuro-Oncol 1984; 2: 253-259.
8. Skarin A, Jochelson M, Sheldon T et al. Neoadjuvant chemotherapy in marginally respectable stage III MO non small cell lung cancer. J Surg Oncol 1989; 40: 266-274.
9. Robnett TJ, Machtay M, Stevenson JP et al. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non small cell lung carcinoma. J Clin Oncol 2001; 19: 1344-1349.
10. Law A, Karp DD, Dipetrill T et al. Emergence of increased cerebral metastases after preoperative radiotherapy with chemotherapy in patients with locally advanced non small cell lung carcinoma. Cancer 2001; 92: 160-164.
11. Ceresoli GL, Reni M, Chiesa G et al. Brain metastases in locally advanced non small cell lung carcinoma after multimodality treatment Risk actor analysis. Cancer 2002; 95: 605-612.
12. André, F, Grunenwald D, Pujol JL et al. Patterns of relapse of N2 non small cell lung carcinoma patients treated with preoperative chemotherapy. Cancer 2001; 91: 2394-2400.
13. Cox JD, Scott CB, Byhardt RW et al. Addition of chemotherapy to radiotherapy alters failure patterns by cell type within non small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1999; 43: 505-509.
14. Perez CA, Pajak TF, Simpson JR et al. Long term observation of the patterns of failure in patients with unresectable non oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987; 59: 1874-1881.
15. Auperin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. N Engl J Med 1999; 341: 476-484.
16. Komaki R, Scott CB, Byhardt R et al. Failure pattern by prognostic group determined by recursive partitioning analysis of 1547 patients on four RTOG studies in inoperable non small cell lung cancer. Int J Radiat Oncol Biol Phys 1998; 42: 263-267.
17. Choi NC, Carey RW, Daly W et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice daily radiation and concurrent chemotherapy in stage IIIA non small cell lung cancer. J Clin Oncol 1997; 15: 712-722.
18. Carolan H, Sun AY, Bezjac A. et al. Does the incidence and outcome of brain metastases il locally advanced non small cell lung cancer justify prophylactic cranial irradiation or early detection? Lung Cancer 2005; 49: 109-114.
19. Bajard A, Westeel V, Dubiez P et al. Multivariate analysis of factors predictive of brain metastases in localized non small cell lung carcinoma. Lung Cancer 2004; 45: 317-323.
20. Yokoi K, Kamiya N, Matsuguma H et al. Detection of brain metastases in potentially operable non small cell lung cancer. A comparison of CT and MRI. Chest 1997; 115: 714-719.
21. Gaspar L, Scott C, Rotman M et al. Recursive partitioning analysis of prognostic factors in three RTOG brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745-751.
22. Miller TP, Crowley JJ, Mira J et al. A randomised trial of chemotherapy and radiotherapy for stage III non small cell lung cancer. Cancer Therapeutics 1998; 4: 229-236.